GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudeep Pharma Ltd
Sudeep Pharma Appoints Milin Mehta as Additional Director
MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 26 Jun 2026, 04:24 PM IST  ·  BSE ID: d5a3ab76-158a-4ea4-9109-998d79e90fc0
View Original BSE Filing (PDF)
💡
In Simple Terms
Sudeep Pharma added a new director, Milin Mehta, to its board who will serve as non-executive and non-independent.
🤖 AI Summary
  • Milin Mehta appointed as Additional Director of Sudeep Pharma.
  • Appointment is Non-Executive and Non-Independent category.
  • Effective date: June 26, 2026, pending shareholder approval.
  • Director has no SEBI or Authority debarment.
🏢 How This Affects the Company
⚙️
Operational Impact
Adds a new member to the Board of Directors, influencing governance and strategic oversight.
⚠️
Risk Impact
No new risks are introduced by this appointment based on the provided information.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholder approval will be sought for the appointment.
👤
Who Is Affected
All shareholders are affected as the board composition and governance structure is updated.
🔍
Management Signal
The appointment signals management's intent to strengthen board oversight and potentially bring in experienced individuals.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting outcome for director approval.
Subsequent board meeting agendas and discussions.
Future announcements regarding director's committee roles.
LOW RISK Appointment of a director is a routine governance event with no inherent immediate risks.
💡 Investor Takeaway
Sudeep Pharma's Board of Directors has appointed Milin Mehta as an Additional Director. This role is Non-Executive, Non-Independent, and effective from June 26, 2026, subject to shareholder confirmation.
❓ Frequently Asked Questions
Who has Sudeep Pharma appointed as an Additional Director?
Sudeep Pharma has appointed Mr. Milin Mehta as an Additional Director.
What is Mr. Milin Mehta's director category at Sudeep Pharma?
Mr. Milin Mehta is appointed as a Non-Executive, Non-Independent Director.
When is the appointment of Mr. Milin Mehta effective?
The appointment of Mr. Milin Mehta is effective from June 26, 2026, subject to shareholder approval.
Has Mr. Milin Mehta been debarred from holding a director's office?
No, it is confirmed that Mr. Milin Mehta has not been debarred from holding the office of Director by any SEBI Order or other Authority.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.